Literature DB >> 16880475

Nephrogenic fibrosing dermopathy and high-dose erythropoietin therapy.

Sundararaman Swaminathan, Iftikhar Ahmed, James T McCarthy, Robert C Albright, Mark R Pittelkow, Noel M Caplice, Matthew D Griffin, Nelson Leung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16880475     DOI： 10.7326/0003-4819-145-3-200608010-00021

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  17 in total

Review 1.  Nephrogenic systemic fibrosis: a concise review for cardiologists.

Authors:  Benjamin Y C Cheong; Raja Muthupillai
Journal:  Tex Heart Inst J       Date:  2010

Review 2.  Conventional or Gadolinium containing contrast media: the choice between acute renal failure or Nephrogenic Systemic Fibrosis?

Authors:  Alexander R Rosenkranz; Thomas Grobner; Gert J Mayer
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

Review 3.  [Nephrogenic systemic fibrosis].

Authors:  Stefan Becker; Oliver Witzke; Andreas Kribben
Journal:  Med Klin (Munich)       Date:  2009-04-01

Review 4.  Nephrogenic systemic fibrosis in liver disease: a systematic review.

Authors:  Sameer M Mazhar; Masoud Shiehmorteza; Chad A Kohl; Michael S Middleton; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2009-12       Impact factor: 4.813

5.  Gadolinium contrast agent-induced CD163+ ferroportin+ osteogenic cells in nephrogenic systemic fibrosis.

Authors:  Sundararaman Swaminathan; Chhanda Bose; Sudhir V Shah; Kimberly A Hall; Kim M Hiatt
Journal:  Am J Pathol       Date:  2013-07-16       Impact factor: 4.307

Review 6.  Nephrogenic systemic fibrosis.

Authors:  Diego R Martin
Journal:  Pediatr Radiol       Date:  2007-12-11

Review 7.  Nephrogenic systemic fibrosis: an emerging entity.

Authors:  Sandip K Saxena; Manjuri Sharma; Mital Patel; Dimitrios Oreopoulos
Journal:  Int Urol Nephrol       Date:  2008-04-17       Impact factor: 2.370

8.  Association of anemia and erythropoiesis stimulating agents with inflammatory biomarkers in chronic kidney disease.

Authors:  Sai Ram Keithi-Reddy; Francesco Addabbo; Tejas V Patel; Bharati V Mittal; Michael S Goligorsky; Ajay K Singh
Journal:  Kidney Int       Date:  2008-06-11       Impact factor: 10.612

Review 9.  Nephrogenic systemic fibrosis: an epidemic of gadolinium toxicity.

Authors:  Derrick J Todd; Jonathan Kay
Journal:  Curr Rheumatol Rep       Date:  2008-07       Impact factor: 4.592

10.  Chronic inflammation and accelerated atherosclerosis as important cofactors in nephrogenic systemic fibrosis following intravenous gadolinium exposure.

Authors:  Scott O Grebe; Marc Borrmann; Alexander Altenburg; Ulrich Wesselman; Dietmar Hein; Patrick Haage
Journal:  Clin Exp Nephrol       Date:  2008-06-14       Impact factor: 2.801
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.